Penn Transplant Institute

The Penn Difference

Patients

Why Patients Choose Penn Medicine

Penn Medicine's transplant program is leading health care beyond the limits of conventional medicine by offering patients more options to improve their lives every day. Patients who choose Penn for their heart transplant have access to the most advanced care available.

Clyde F. Barker Penn Transplant House

Clyde F. Barker Penn Transplant House

A guest house for transplant families, caregivers and patients, the Clyde F. Barker Penn Transplant House provides comfortable accommodations and convenient services at nominal cost.

Learn more about the Clyde F. Barker Penn Transplant House

Penn Medicine's transplant programs have established national reputations with a number of noteworthy attributes.

Heart Transplant

  • Ranked among the top three heart transplant programs in the country**
  • Performs more adult heart transplants per year than all other Philadelphia area hospitals combined, making it one of the top five heart transplantation programs in the nation
  • Performed more than 800 heart transplants since the program began in 1988.
  • Survival rates at one-month, one-year, and three-year post-transplant consistently exceed national averages and are among the highest in the state and region.
  • Received the Medal of Honor for Organ Donation from The Joint Commission
  • Was the first heart transplant center in the region to receive certification for temporary total artificial heart (TAH-t) implantation
  • Establishes new scientific partnerships to give patients early access to the latest in mechanical devices that support or replace heart functions

Kidney Transplant

  • Performs nearly 200 kidney transplants every year, making Penn's kidney transplant program the largest and most experienced kidney transplant program in the region.
  • Since the program's first kidney transplant in 1966, Penn transplant surgeons have performed more than 4,100 kidney transplants and consistently achieve transplant survival rates that exceed national averages.
  • An active living donor program, offering patients an excellent alternative to a long waiting time for a kidney

Liver Transplant

  • One of the most comprehensive, high volume centers in the country for patients with end-stage liver disease
  • Offers liver transplant as treatment for hepatobiliary tumor and hepatocellular carcinoma (HCC) liver cancer
  • Liver transplant outcomes that meet or exceed national averages
  • An active living donor program offers patients an excellent alternative to a long waiting time for a liver transplant.

Lung Transplant

  • Over the past five years, Penn has performed more than double the number of lung transplants than any transplant program in the Philadelphia region. It is one of the most experienced teams in the nation.
  • The Hospital of the University of Pennsylvania is consistently ranked as one of the top hospitals in the United States and among the nation's leaders in pulmonary disorders by U.S. News & World Report.
  • Access to clinical trials and emerging research for advanced lung disease and lung transplantation
  • A specialized team of lung transplant pulmonologists, cardiothoracic surgeons, nurse practitioners, chest radiologists, physical and respiratory therapists, financial counselors and social workers; all dedicated to caring for patients and their loved ones through the transplant process
  • A streamlined referral process and standard three-day patient evaluation designed to safely and efficiently move patients through the transplant listing process

Pancreas and Islet Cell Transplant

The Penn-CHOP Partnership

Penn Medicine and the Children's Hospital of Philadelphia (CHOP) have partnered for decades in caring for children requiring transplants.

The transplant center at Children's Hospital of Philadelphia (CHOP) is one of the largest multi-organ pediatric transplant centers in the country and its team members are committed to improving the health and lives of children needing transplants. Penn surgeons work hand-in-hand with the pediatric transplant specialists in the kidney and liver transplant programs to perform the transplants at CHOP. In addition, the Penn Transplant Institute has established a joint program with CHOP to allow healthy adult relatives to donate organ tissue to children with end-stage kidney or liver disease. The surgery on the adult donor is performed next door at the Hospital of the University of Pennsylvania, and the child's transplant is performed at CHOP.

Besides living donor transplant, another important aspect of this combined effort is the ability to split deceased donor livers so that a small part goes to a child, and the larger segment goes to an adult, helping two recipients with one donor liver.

* Data source: UNOS/Scientific Registry of Transplant Recipients (SRTR). For Patients Receiving their First Transplant of this type between 01/01/2008 and 06/30/2010 for the 1 Month and 1 Year Models; between 07/01/2005 and 12/31/2007 for the 3 Year Model. SRTR data last published: July 2011.

** Data Source: OPTN/SRTR Center and OPO specific reports (June 2010): Organ Procurement and Transplantation Network and Scientific Registry of Transplant Recipients; available at www.OPTN.org and www.ustransplant.org.